Fredun Pharmaceuticals Limited (BSE: 539730), a leading provider of Pharmaceuticals and innovative healthcare solutions for veterinary applications. Fredun Pharmaceuticals is coming up with a cutting-edge manufacturing facility in Palghar, Maharashtra, which will be dedicated to the production of functional foods for pets. Conceptualized and construction is underway, it will begin operations by the third quarter of FY26, this plant is poised to play a crucial role in addressing the nutritional needs and chronic health concerns of pets in India.
As pet ownership in India evolves, pet parents are becoming increasingly aware of the importance of their pet's health and the impact of nutrition on chronic diseases. Functional foods are emerging as a key component in preventing diet-related illnesses and ensuring a healthier future for pets and their families. Fredun Pharmaceuticals functional food factory is not only equipped with cutting-edge technology but will also focus on manufacturing products to prevent chronic diseases, such as heart disease, diabetes, and certain cancers.
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India. With this strategic move, Fredun is poised to become one of the pioneers in the market, providing high-quality, in-house manufactured functional foods designed to meet the nutritional needs of pets. The factory is being constructed with the aim of achieving the highest accreditations in the industry, positioning it as a premier source for top veterinary companies worldwide. While prioritizing the production of Fredun Brands, the facility will also serve white labeling clients for both the domestic and export markets, showcasing the company's versatility and commitment to quality.
The pet care industry in India has witnessed exponential growth, and Fredun Pharmaceuticals is strategically positioned to capitalize on this trend. The company's investment in the new plant is expected to significantly contribute to the growth of its pet care segment, further strengthening its market position.
Commenting on the Development, Mr. Fredun Medhora, Managing Director, said: "Our new functional food factory will not only be state-of-the-art but will also concentrate on crafting products that safeguard against chronic diseases, shaping a healthier tomorrow for pets and their owners. We recognize the evolving needs of Indian pet parents and are committed to meeting these with our innovative solutions. Machinery procurement is already in progress, and we are on track to be fully operational by Q3 FY26. This expansion is not just about growth; it's about our responsibility to pet health and the trust that pet parents place in us."
Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 706.85 as compared to the previous close of Rs. 708.25. The total number of shares traded during the day was 7244 in over 169 trades.
The stock hit an intraday high of Rs. 718.90 and intraday low of 698.00. The net turnover during the day was Rs. 5123394.00. |
